SEC Form 4 research
| Issuer | C4 Therapeutics, Inc. |
|---|---|
| Tickers | CCCC |
| Reporting owners | 27 |
| Officers and directors | 11 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-10-01 | Anderson Kenneth Carl | A | 3,662 | $3.14 | Not reported |
| 2026-10-02 | 2026-10-01 | GROGAN DONNA ROY | A | 4,618 | $3.14 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.